ASYS vs GSK · rev $61.8M vs P/E 13, $103.31B cap
Amtech Systems Inc (ASYS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Amtech Systems Inc (ASYS) is a semiconductor equipment & materials company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ASYS revenue for 2026-06-30 was $61.8M. Net income was $2.9M. Revenue was up 56.8% from 2026-03-31 to 2026-06-30. ASYS currently screens at market cap $64.1M.
GSK does not have a complete income-statement cache yet.
ASYS currently screens at market cap $64.1M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ASYS and GSK stock pages for the full models.
Not investment advice.